What’s New in PAH in 2024
Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.

Author

This post was published by The APAPP staff on behalf of the author(s) – listed above.
Is this SOB my problem or yours? : Referral to Cardiology
Previous

Is this SOB my problem or yours? : Referral to Cardiology
Next

PFT 101